ACV meeting #19, 3 February 2021

The meeting of the Advisory Committee on Vaccines (ACV).

The committee provided further advice and endorsed the COVID-19 Vaccine Pharmacovigilance Plan, which had been amended following the ACV meeting #16 held 30 September 2020.

Members

Membership comprises professionals with expertise in specific scientific, medical or clinical fields, or consumer health issues.